Healthcare ❯ Pharmaceutical Industry

Drug Pricing

Medicare Medicare Negotiations Regulations Medicaid and Medicare Regulatory Actions Government Regulation NHS International Trade Legislation Market Dynamics Cost Efficiency US-UK Agreement Market Regulations Insurance Negotiations Supply Chain Management Regulatory Issues Patient Access Medicare Negotiation Program Reforms Government Regulations Inhalers Generic Drugs U.S. Market Research Facilities Weight-Loss Drugs Price Controls Import Taxes Insurance Cost Reduction Strategies Government Policies Tariff Implications Eliquis Investigations Medication Prices Negotiation Programs Negotiations Insulin

Pfizer Sets 2026 Targets Below Wall Street as COVID Sales Fade, Patent Pressure Builds

Executives blame weaker COVID demand alongside pending patent losses, signaling a near-term reset toward pipeline investment.

Trump Vows Unachievable 1,400% Drug Price Cuts, Threatens Trade Sanctions